UK-BaCWAN2: Continuation and Expansion of UK-Bacterial Cell Wall Assembly Network
Lead Research Organisation:
University of Sheffield
Department Name: Molecular Biology and Biotechnology
Abstract
Millions of people die each year from bacterial infections and tens of millions suffer from the consequences of these infections. The discovery of the antibiotic penicillin once opened the door to treat these infections by stopping bacteria making the polymer in the cell wall that holds them together. This polymer, called peptidoglycan, is made up of an interlocking network of sugars and strings of amino acids (peptides). Specialised proteins (called PBPs), with the ability to stitch together these sugars and peptides are the targets inhibited by penicillin, stopping cell wall synthesis and killing the bacterium. Many important bacteria are now no longer killed by penicillin and other antibiotics that attack other stages in the production of peptidoglycan. Bacteria have changed, evading the action of these antibiotics. We need to fight back, by using the advanced computing power at our disposal to design new classes of antibiotics, compounds that will work against multiply resistant bacteria like MRSA, and help combat the harmful effects of our immune system when it over responds to infection.
BACWAN consists of a group of scientists from academia, industry and government whose goals is increase and coordinate activity in his area to bring about new treatments and strategies. They will have, for the first time, the combined tools and new chemical reagents (to be made for the team at a cost efficient central location at Warwick) to look in minute detail how peptidoglycan is made, how we could stop this process by the development of new inhibitors (antibiotics) and how fragments of peptidoglycan interact with our bodies during the process of infection. This capacity for discovery, being lost elsewhere, will provide a unique forum for the development of new compounds.
BACWAN consists of a group of scientists from academia, industry and government whose goals is increase and coordinate activity in his area to bring about new treatments and strategies. They will have, for the first time, the combined tools and new chemical reagents (to be made for the team at a cost efficient central location at Warwick) to look in minute detail how peptidoglycan is made, how we could stop this process by the development of new inhibitors (antibiotics) and how fragments of peptidoglycan interact with our bodies during the process of infection. This capacity for discovery, being lost elsewhere, will provide a unique forum for the development of new compounds.
Technical Summary
The process of assembly of the bacterial cell wall is a validated and important target for the development of novel antibacterial agents, and is intimately connected with the emergence of antibiotic resistance around the world. Significant research programmes in this area are carried out in UK laboratories, but at present these activities are somewhat fragmented, between groups in Chemistry, Physics, and Biology departments following different areas related to this problem. Our existing UK Network in bacterial cell wall assembly, has been successful in bringing together some of these groups with expertise in different disciplines and provide a forum for the additional involvement of industrial and healthcare associated scientists, to inform the network of industrial interests and emerging techniques and areas of interest. We now wish to capitalise and expand upon this network by recruiting further members and promoting excellent scientific collaboration. The principal vehicle for this network will be a series of bi-yearly meetings involving chemists, biochemists, microbiologists, computational, industrial and physical scientists to stimulate new inter-disciplinary research and collaboration in this area. Our website provides a useful additional level of information for our members and distributes information to members, other scientists and the general public will also augment these meetings. We also wish to facilitate new collaborative research programmes that will arise from this network by funding inter-laboratory and interdisciplinary visits for students, postdoctoral researchers and PIs, enabling technology and technique transfer to stimulate future research efforts within the UK scientific community.